AMY STOWERS: Open Payments
NPI 1013005263 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 78 payments from 15 companies in 2025. Trend: 2023 $1,368 · 2024 $983 · 2025 $1,844
Food & beverage: $1,844
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $521 |
| Janssen Biotech, Inc. | 16 | $492 |
| Regeneron Healthcare Solutions, Inc. | 11 | $342 |
| NeurAxis, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 5 | $69 |
| Ardelyx, Inc. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 2 | $31 |
Products named: TREMFYA, RINVOQ, DUPIXENT, CREON, ENTYVIO, VOQUEZNA, LINZESS, SKYRIZI.
Industry payments across VA — which companies pay providers there.
